Advisor Group Holdings, Inc. Aim Immuno Tech Inc. Transaction History
Advisor Group Holdings, Inc.
- $44.4 Billion
- Q2 2025
A detailed history of Advisor Group Holdings, Inc. transactions in Aim Immuno Tech Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 1,001 shares of AIM stock, worth $2,632. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,001
Previous 1,001
-0.0%
Holding current value
$2,632
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding AIM
# of Institutions
9Shares Held
811KCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY698KShares$1.84 Million0.0% of portfolio
-
Cordasco Financial Network500Shares$1,3150.0% of portfolio
-
American Portfolios Advisors Holbrook, NY228Shares$5990.0% of portfolio
-
Jpmorgan Chase & CO New York, NY127Shares$3340.0% of portfolio
-
Mai Capital Management27Shares$710.0% of portfolio
About AIM ImmunoTech Inc.
- Ticker AIM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,049,300
- Market Cap $126M
- Description
- AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome...